Movicol Junior

Macrogol 3350, the active ingredient in Movicol Junior, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to relieve constipation in children and adolescents by softening stool and facilitating bowel movements.

GNH USA supplies Movicol Junior as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable and efficient global distribution to meet the needs of pediatric care providers.

Movicol Junior, an osmotic laxative, is indicated for conditions affecting bowel motility and stool consistency. - Constipation in children: softens stool and promotes regular bowel movements. - Functional constipation: helps restore normal bowel function in pediatric patients. - Chronic idiopathic constipation: provides long‑term relief of persistent constipation in children.

Movicol Junior may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild discomfort or urge to vomit. - Diarrhoea: loose, watery stools occurring more frequently. - Flatulence: increased gas production leading to passing of wind. - Cramping: intermittent abdominal pain or muscle spasms.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium or potassium that may affect heart rhythm. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent abdominal pain: ongoing severe pain not relieved by usual measures.

Before using Movicol Junior, consider the following safety measures to minimize risk. - Assess hydration status: ensure the child is adequately hydrated before initiating therapy. - Review electrolyte levels: monitor sodium and potassium if prolonged use is anticipated. - Avoid use in intestinal obstruction: contraindicated when bowel blockage is present. - Use with caution in renal impairment: adjust therapy and monitor renal function. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Movicol Junior can interact with other medicines, altering their absorption or electrolyte balance.

Major Interactions (Avoid): - Lithium: increased lithium levels may lead to toxicity. - Digoxin: electrolyte shifts can enhance digoxin toxicity risk. - Antacids containing aluminium or magnesium: may reduce laxative effectiveness.

Moderate Interactions (Monitor Closely): - Oral antibiotics: reduced absorption may diminish antibiotic efficacy. - Diuretics: concurrent use may exacerbate electrolyte disturbances. - Iron supplements: may decrease absorption of iron.